Investor Stock List
Ranked #2,299 of 8,699 institutional investors

Boxer Capital Management, LLC

San Diego, CA

$1.04B
US stock portfolio at live prices · today −$840K (−0.08%)
Market closed. Prices as of Nov 20, 9:11 AM ET
Value at quarter end (Q3 2026)
$1.15B
Change from Q2 2026
−$177.1M (−13.34%)
Positions
44 · 12 new, 22 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$58.0M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
TNGX 22.9%KOD 13.9%REPL 7.90%RVMD 7.65%KYMR 6.01%
StockSharesValue, live% of portfoliovs Q2 2026
TNGX Tango Therapeutics, Inc.10,526,219$239M22.9%Reduced −3%
KOD Kodiak Sciences Inc.1,477,600$145M13.9%Unchanged
REPL Replimune Group, Inc.4,278,159$82.3M7.90%Added +7%
RVMD Revolution Medicines, Inc.500,000$79.7M7.65%Unchanged
KYMR Kymera Therapeutics, Inc.524,551$62.6M6.01%Added +22%
SRZN Surrozen, Inc.1,360,683$41.7M4.01%Added +23%
ABVX ABIVAX Société Anonyme474,971$38.3M3.68%Reduced −21%
SYRE Spyre Therapeutics, Inc.283,054$27.6M2.65%Added +183%
AMLX Amylyx Pharmaceuticals, Inc.893,153$23.4M2.25%Added +12%
QTTB Q32 Bio Inc.2,577,642$21.9M2.10%Reduced −18%
CORT Corcept Therapeutics Incorporated335,500$21.8M2.09%Unchanged
PTGX Protagonist Therapeutics, Inc.170,000$21.1M2.02%Unchanged
DFTX Definium Therapeutics, Inc.683,615$20.2M1.93%Reduced −32%
IRD Opus Genetics, Inc.4,533,660$18.5M1.78%Added +61%
PGEN Precigen, Inc.4,320,339$18.0M1.72%Reduced −16%
CELC Celcuity Inc.286,239$16.1M1.55%Reduced −31%
QUIT Achieve Life Sciences, Inc.2,150,000$12.6M1.21%New
TRAX First Tracks Biotherapeutics, Inc.240,000$10.7M1.02%New
CCCC C4 Therapeutics, Inc.4,150,000$10.1M0.97%New
SABS SAB Biotherapeutics, Inc.2,500,000$7.3M0.70%New
MAZE Maze Therapeutics, Inc.175,465$5.7M0.55%New
STTK Shattuck Labs, Inc.1,175,396$5.3M0.51%Added +18%
CYTK Cytokinetics, Incorporated100,000$5.1M0.49%Unchanged
ANTX AN2 Therapeutics, Inc.944,035$4.9M0.47%Added +26%
CAPR Capricor Therapeutics, Inc.642,837$4.8M0.46%Reduced −54%
CTNM Contineum Therapeutics, Inc.494,000$4.5M0.43%Unchanged
PALI Palisade Bio, Inc.4,799,875$4.4M0.43%Unchanged
CGEM Cullinan Therapeutics, Inc.450,000$4.1M0.39%New
ETRA Electra Therapeutics, Inc.450,000$4.0M0.39%New
RLAY Relay Therapeutics, Inc.200,000$3.2M0.31%Reduced −56%
ATTO Attovia Therapeutics, Inc.200,000$3.1M0.30%New
PMVP PMV Pharmaceuticals, Inc.2,050,000$2.7M0.26%New
SRPT Sarepta Therapeutics, Inc.150,000$2.1M0.20%Unchanged
EDSA Edesa Biotech, Inc.937,363$2.0M0.20%Added +357%
KZIA Kazia Therapeutics Limited371,500$2.0M0.19%Reduced −34%
CLNN Clene Inc.477,515$1.7M0.16%Unchanged
ZNTL Zentalis Pharmaceuticals, Inc.1,013,555$1.4M0.13%New
NRIX Nurix Therapeutics, Inc.100,000$1.4M0.13%Unchanged
SION Sionna Therapeutics, Inc.391,723$1.2M0.11%New
ACRS Aclaris Therapeutics, Inc.300,000$1.1M0.10%New
ALLO Allogene Therapeutics, Inc.1,500,000$1.0M<0.1%Unchanged
NMRA Neumora Therapeutics, Inc.954,052$331K<0.1%Reduced −52%
MIST Milestone Pharmaceuticals Inc.666,666$266K<0.1%Unchanged
KPTIQ Karyopharm Therapeutics Inc.127,536$4K<0.1%Reduced −58%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
PCVX Vaxcyte, Inc.325,000$19.0M
VIR Vir Biotechnology, Inc.1,866,000$16.6M
PRAX Praxis Precision Medicines, Inc.46,457$14.4M
PTCT PTC Therapeutics, Inc.200,000$11.7M
CRVS Corvus Pharmaceuticals, Inc.1,100,000$11.0M
OCUL Ocular Therapeutix, Inc.1,300,000$7.6M
COGT Cogent Biosciences, Inc.225,000$6.2M
ODTX Odyssey Therapeutics, Inc.275,000$5.0M
INO Inovio Pharmaceuticals, Inc.2,844,994$4.9M
MLTX MoonLake Immunotherapeutics275,000$3.0M
LBRX LB Pharmaceuticals Inc70,000$2.8M
ORIC ORIC Pharmaceuticals, Inc.350,000$2.7M
RLMD Relmada Therapeutics, Inc.842,106$2.6M
AVTX Avalo Therapeutics, Inc.375,000$2.5M
SLDB Solid Biosciences Inc.300,000$1.9M
FTH Faeth Therapeutics, Inc.180,505$1.6M
GPCR Structure Therapeutics Inc.75,000$1.3M
PEPG PepGen Inc.272,892$1.1M
IVVD Invivyd, Inc.1,500,000$669K
MPLT MapLight Therapeutics, Inc.75,000$482K
UPB Upstream Bio, Inc.150,000$300K
RGNX REGENXBIO Inc.15,000$108K